Drugs for Cleft Palate, Isolated (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 75)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Cathine |
Approved, Experimental, Illicit, Vet_approved, Withdrawn |
Phase 4 |
|
14838-15-4, 492-39-7 |
131954576 4786 26934 |
Synonyms:
(+-)-Norephedrine
(+)-Norpseudoephedrine
(+-)-Phenylpropanolamine
2-AMINO-1-PHENYLPROPAN-1-OL
Cathina
Cathine
Cathinum
D-Cathine
Dexatrim
DL-Norephedrine
DL-Phenylpropanolamine
D-Norephedrine
d-Norpseudoephedrine
d-Nor-psi-ephedrine
FENILPROPANOLAMINA
Hydriatine
Hydrochloride, phenylpropanolamine
Katine
L-NOREPHEDRINE
L-Phenyl propanolamine
|
Mucorama
Nobese
NOREPHEDRIN
Norephedrine
Obestat
PHENYLPROPANOLAMIN
Phenylpropanolamina
Phenylpropanolamine
PHÉNYLPROPANOLAMINE
Phenylpropanolamine hydrochloride
PHENYLPROPANOLAMINUM
PPA
Prestwick_388
Prolamine
Propadrine
Propagest
Pseudonorephedrine
psi-Norephedrine
Triaminic DM
Î’-HYDROXYAMPHETAMINE
|
|
2 |
|
Guaifenesin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
93-14-1 |
3516 |
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
Amonidren
Amonidrin
AMONIDRON
Aresol
Benylin-e
Breonesin
Bronchol
CVT-2534
Ether, guaiacol glyceryl
FAMEL
FRANOLYN CHESTY
GECOLATE
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl ether, guaiacol
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
Glycerylguaiacol
|
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolate, glycerol
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
GUAIFENESIN OR GUAIPHENESIN
Guaifenesina
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphenezine
Guaiphesin
Guiatuss
HUMABID
Humibid
Hustosil
Hytuss
LIQUFRUTA
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
MUCINEX
NIROLEX FOR CHESTY COUGH DECONGESTANT
NSC-62112
O-Methoxyphenyl glyceryl ether
Organidin NR
p-Cresyl acetate
Pneumomist
Propanosedyl
Reduton
Robitussin
Scott tussin
Scott-tussin
ScottTussin
TIXYLIX CHESTY COUGH
|
|
3 |
|
Codeine |
Approved, Illicit |
Phase 4 |
|
76-57-3, 6854-40-6 |
5284371 5362471 |
Synonyms:
(-)-Codeine
(−)-CODEINE
(1S,13R,14S,17R)-10-Methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0(1,13).0(5,17).0(7,18)]octadeca-7(18),8,10,15-tetraen-14-ol
(5a,6a)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol
(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol
(5Α,6α)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol
3-METHYLMORPHIN
3-METHYLMORPHINE
7,8-Didehydro-4,5a-epoxy-3-methoxy-17-methylmorphinan-6a-ol
7,8-Didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol
7,8-Didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol
Ardinex
Codein
Codeina
CODEÍNA
CODEINE
CODÉINE
Codeine anhydrous
CODEINE MONOHYDRATE
|
Codeine phosphate
CODEINE POLISTIREX
CODEINUM
Codicept
Codicept®|methylmorphine
Coducept
IDS-NC-005(SECT.-2)
Isocodeine
L-Codeine
Methylmorphine
Morphine 3-methyl ether
Morphine monomethyl ether
Morphine-3-methyl ether
N Methylmorphine
N-Methylmorphine
Norcodeine, N-methyl
Norcodine, N-methyl
O(3)-Methylmorphine
O3-Methylmorphine
|
|
4 |
|
Tranexamic acid |
Approved |
Phase 4 |
|
1197-18-8 |
5526 |
Synonyms:
(1R,4R)-4-(AMINOMETHYL)CYCLOHEXANE-1-CARBOXYLIC ACID
Acide tranexamique
Acide tranéxamique
Acido tranexamico
ácido tranexámico
Acidum tranexamicum
CL-65336
CL-65336|Cyclo-F®|Cyklokapron®|Femstrual®|trans AMCHA
CYCLO-F
CYKLO-F HEAVY PERIOD RELIEF
Cyklokapron
EXACYL
FEMSTRUAL
LB1148
LB-1148
LYSTEDA
MENSTRALITE
|
NSC-291305
RP-18429
Tranexamate
Tranexamic acid
Tranexamsaeure
Tranexmate
Tranexmic acid
Tranhexamate
Tranhexamic acid
trans AMCHA
trans-4-(Aminomethyl)cyclohexanecarboxylate
trans-4-(Aminomethyl)cyclohexanecarboxylic acid
trans-4-AMINOMETHYLCYCLOHEXANE-1-carboxylate
trans-4-AMINOMETHYLCYCLOHEXANE-1-carboxylIC ACID
trans-Amcha
trans-Tranexamate
trans-Tranexamic acid
|
|
5 |
|
Bupivacaine |
Approved, Investigational |
Phase 4 |
|
2180-92-9, 38396-39-3 |
2474 |
Synonyms:
(+-)-Bupivacaine
(±)-bupivacaine
(RS)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
Abbott brand OF bupivacaine hydrochloride
ANEKAIN
Anhydrous, bupivacaine
Astra brand OF bupivacaine hydrochloride
AstraZeneca brand OF bupivacaine hydrochloride
Aventis brand OF bupivacaine hydrochloride
Bloqueina
Braun brand OF bupivacaine hydrochloride
Braun, bupivacaina
Bucaine
Bupivacain janapharm
Bupivacain RPR
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaina braun
BUPIVACAINE
Bupivacaine anhydrous
Bupivacaine carbonate
Bupivacaine HCL
Bupivacaine HCL kit
Bupivacaine hydrochloride
Bupivacaine monohydrochloride, monohydrate
Bupivacain-RPR
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
Buvacaina
|
Carbonate, bupivacaine
Carbostesin
CBupivacaine
Chirocaine
DepoBupivacaine
dl-1-Butyl-2',6'-pipecoloxylidide
DL-Bupivacaine
DL-Bupivacaine|Exparel®|Marcain®|Posimir®|Sensorcaine®|W-7|Xaracoll®
Dolanaest
DUR-843
Exparel
Hydrochloride, bupivacaine
Inibsa brand OF bupivacaine hydrochloride
Janapharm, bupivacain
Jenapharm brand OF bupivacaine hydrochloride
LAC-43
LIQ865
LIQ-865
Marcain
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
Pisa brand OF bupivacaine hydrochloride
Racemic bupivacaine
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
SKY-0402
Strathmann brand OF bupivacaine hydrochloride
Svedocain sin vasoconstr
Transdur-Bupivacaine
|
|
6 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
7 |
|
Antitussive Agents |
|
Phase 4 |
|
|
|
8 |
|
Chlorpheniramine, phenylpropanolamine drug combination |
|
Phase 4 |
|
|
|
9 |
|
Antifibrinolytic Agents |
|
Phase 4 |
|
|
|
10 |
|
Anesthetics, Local |
|
Phase 4 |
|
|
|
11 |
|
Anesthetics |
|
Phase 4 |
|
|
|
12 |
|
Analgesics, Opioid |
|
Phase 4 |
|
|
|
13 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
14 |
|
Levobupivacaine |
Approved, Investigational |
Phase 2, Phase 3 |
|
27262-47-1 |
92253 |
Synonyms:
(-)-Bupivacaine
(S)-1-Butyl-2',6'-pipecoloxylidide
(S)-Bupivacaine
BUPIVACAINE (-)-FORM
Chirocaine
L-(-)-1-Butyl-2',6'-pipecoloxylidide
|
L-(−)-bupivacaine
L-(-)-Bupivacaine
Levobupivacaína
LEVOBUPIVACAINE
Levobupivacaine hydrochloride
Novabupi
|
|
15 |
|
Levoleucovorin |
Approved, Experimental, Investigational |
Phase 3 |
|
68538-85-2, 58-05-9, 73951-54-9 |
149436 6006 |
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R)-Leucovorin
(6R,2'S)-Folinic acid
(6R,S)-5-Formyltetrahydrofolate
(6S)-5-Formyl-5,6,7,8-tetrahydrofolate
(6S)-5-FORMYL-5,6,7,8-TETRAHYDROFOLIC ACID
(6S)-5-Formyltetrahydrofolate
(6S)-5-FORMYLTETRAHYDROFOLIC ACID
(6S)-Folinate
(6S)-FOLINIC ACID
(6S)-LEUCOVORIN
(S)-LEUCOVORIN
[6R]-5-formyl-5,6,7,8-tetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formlyl-5,6,7,8-tetrahydrofolate,calcium salt
5-Formyl-(6S)-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formylTHF
6 S Leucovorin
6R-Leucovorin
6S Leucovorin
6S-Leucovorin
6-S-Leucovorin
Acid, folinic
Acide folinique
Acido folinico
ácido levofolínico
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
CF
Citrovorum factor
Dextrofolinic acid
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
FUSILEV
KHAPZORY
|
Kunyrin
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucoverin
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, (S)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, (S)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monopotassium salt, (S)-isomer
Leucovorin, monosodium salt
Leucovorin, monosodium salt, (S)-isomer
Leucovorinum
Leukovorin
Leukovorum
Levo leucovorin
LEVOFOLENE
Levofolinate
LEVOFOLINIC ACID
Levoleucovorin
Levo-leucovorin
L-Folinate
L-FOLINIC ACID
LFP-754
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate
N-[4-({[(6S)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID
N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
N5-Formyl-THF
Pteroyl-D-glutamate
Rescuvolin
S Leucovorin
S-Leucovorin
Welcovorin
Wellcovorin
|
|
16 |
|
Nalbuphine |
Approved |
Phase 3 |
|
20594-83-6 |
5311304 |
Synonyms:
Hydrochloride, nalbuphine
Intapan
Nalbufina
NALBUPHIN
NALBUPHINE
Nalbuphine hydrochloride
Nalbuphine serb
Nalbuphine serb brand
|
Nalbuphinum
N-Cyclobutylmethyl-4,5a-epoxy-3,6a,14-morphinantriol
N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol
N-Cyclobutylmethyl-4,5α-epoxy-3,6α,14-morphinantriol
Nubain
Nubain®
SERB brand OF nalbuphine
Serb, nalbuphine
|
|
17 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 3 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID
(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID
[<sup>3</sup>H]-folic acid
Acide folique
ácido fólico
Acidum folicum
ACIFOLIC
Apo-Folic
B03BB01
b9, Vitamin
BIO SCIENCE
CYTOFOL
DOSFOLAT B ACTIV
FOLACID
FOLACIN
FOLATE
FOLBAL
FOLCIDIN
FOLDINE
FOLETTES
FOLIAMIN
FOLIC ACID
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
FOLICARE
FOLICET
FOLIPAC
|
FOLSAEURE
FOLSAN
FOLSAURE
Folsäure
FOLSAV
FOLVITE
Folvron
INCAFOLIC
LEXPEC
LIVER LACTOBACILLUS CASEI FACTOR
MILLAFOL
N-(4-{[(2-AMINO-4-OXO-3,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)-L-GLUTAMIC ACID
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)CARBONYL]-L-GLUTAMIC ACID
N-[4-[[(2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL]AMINO]BENZOYL]-L-GLUTAMIC ACID
NATUR FLOW
N-Pteroyl-L-glutamate
N-PTEROYL-L-GLUTAMIC ACID
NSC-3073
PGA
PRECONCEIVE
PTEGLU
PTEROYLGLUTAMATE
PTEROYLGLUTAMIC ACID
PTEROYL-L-GLUTAMATE
PTEROYL-L-GLUTAMIC ACID
PTEROYL-L-MONOGLUTAMATE
PTEROYL-L-MONOGLUTAMIC ACID
PTEROYLMONOGLUTAMIC ACID
ROCHE
Vitamin B9
VITAMIN BC
VITAMIN BE
VITAMIN M
|
|
18 |
|
Folate |
|
Phase 3 |
|
|
|
19 |
|
Vitamin B9 |
|
Phase 3 |
|
|
|
20 |
|
Trace Elements |
|
Phase 3 |
|
|
|
21 |
|
Vitamin B Complex |
|
Phase 3 |
|
|
|
22 |
|
Hematinics |
|
Phase 3 |
|
|
|
23 |
|
Micronutrients |
|
Phase 3 |
|
|
|
24 |
|
Narcotics |
|
Phase 3 |
|
|
|
25 |
|
Acetylcholine |
Approved, Investigational |
Phase 1, Phase 2 |
|
51-84-3 |
187 |
Synonyms:
[2-(ACETYLOXY)ETHYL]TRIMETHYLAZANIUM
2-(Acetyloxy)-N,N,N-trimethylethanaminium
2-ACETOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AZANIUM
Acetilcolina cusi
Acetyl choline ion
Acetylcholine
Acetylcholine bromide
Acetylcholine cation
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
ACETYLCHOLINE, ACH
Acetylcholinium: acetyl-choline
|
ACh
ACh|E1001|O-acetylcholine
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
E1001
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
26 |
|
Ampicillin |
Approved, Vet_approved |
Phase 2 |
|
69-53-4 |
6249 |
Synonyms:
(2S,5R,6R)-6-[[(2R)-2-Amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylIC ACID
(2S,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
6-(a-Aminophenylacetamido)penicillanic acid
6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid
6-(D-(2-Amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
6-(D-(2-Amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9ci
6-D(-)-alpha-Aminophenylacetamido-penicillanic acid
ABPC
Acillin
Adobacillin
Alpen
alpha-Aminobenzylpenicillin
Amblosin
Amcill
Amfipen
Amfipen V
Aminobenzyl penicillin
Aminobenzylpenicillin
Amipenix S
AMP
Ampen
AMPI
Ampi-bol
Ampichel
Ampicil
Ampicilina
AMPICILLIN
Ampicillin (anhydrous)
Ampicillin acid
Ampicillin anhydrate
Ampicillin anhydrous
Ampicillin base
Ampicillin sodium
Ampicillin trihydrate
Ampicillin, anhydrous
AMPICILLIN/AMPICILLIN TRIHYDRATE
Ampicillina
Ampicilline
Ampicillinum
Ampi-co
Ampifarm
Ampikel
AMPILAR
Ampimed
Ampipenin
Ampiscel
Ampisyn
Ampi-tab
Ampivax
Ampivet
Amplacilina
Amplin
Amplipenyl
Amplisom
Amplital
Anhydrous ampicillin
Antibiotic KS R1
Antibiotic KS-R1
AP
Austrapen
AY 6108
AY-6108
Bayer 5427
Binotal
Bonapicillin
Britacil
BRITCIN
BRL 1341
BRL-1341
Campicillin
Cimex
Copharcilin
D-(-)-6-(a-Aminophenylacetamido)penicillanate
D-(-)-6-(a-Aminophenylacetamido)penicillanic acid
D-(-)-6-(alpha-Aminophenylacetamido)penicillanate
D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid
D-(-)-6-(Α-aminophenylacetamido)penicillanate
D-(-)-6-(Α-aminophenylacetamido)penicillanic acid
D-(−)-6-(Α-AMINOPHENYLACETAMIDO)PENICILLANIC ACID
D-(-)-alpha-Aminobenzylpenicillin
D-(-)-alpha-Aminopenicillin
|
D-(-)-Ampicillin
D-(−)-AMPICILLIN
D-a-Aminobenzylpenicillin
D-Ampicillin
D-Cillin
Delcillin
Deripen
Divercillin
Doktacillin
Duphacillin
Geocillin
Grampenil
Guicitrina
Guicitrine
KS-R1
KS-R1, Antibiotic
Lifeampil
Magnapen
Marcillin
Morepen
Norobrittin
Novo-ampicillin
NSC 528986
NSC-528986
Nuvapen
Olin kid
Omnipen
OMNIPEN-N
Orbicilina
P-50
Pen a
Pen ampil
Penbristol
Penbritin
PENBRITIN-S
Penbrock
Penicillin, aminobenzyl
Penicline
Penimic
Pensyn
Pentrex
Pentrexl
Pentrexyl
Pentritin
Pfizerpen a
PFIZERPEN-A
Polycillin
POLYCILLIN-N
POLYCILLIN-PRB
Ponecil
Princillin
Principen
PRINCIPEN '125'
PRINCIPEN '250'
PRINCIPEN '500'
PROBAMPACIN
Qidamp
Racenacillin
Ro-ampen
Rosampline
Roscillin
Semicillin
Servicillin
SK-Ampicillin
Sodium, ampicillin
Sumipanto
Supen
Synpenin
Texcillin
Tokiocillin
Tolomol
Totacillin
TOTACILLIN-N
Totalciclina
Totapen
Trifacilina
Trihydrate, ampicillin
Ukapen
Ultrabion
Ultrabron
Vampen
Viccillin
Vidocillin
Vidopen
WY 5103
Wypicil
|
|
27 |
|
Sulbactam |
Approved |
Phase 2 |
|
68373-14-8 |
5316 |
Synonyms:
(2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid 4,4-dioxide
(2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
Bétamaze
Combactam
Penicillanic acid 1,1-dioxide
Penicillanic acid sulfone
|
Sodium, sulbactam
Sulbactam
Sulbactam sodium
Sulbactamum
Sulfone, penicillanic acid
|
|
28 |
|
Benzocaine |
Approved, Investigational |
Phase 1, Phase 2 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
29 |
|
Tannic acid |
Approved |
Phase 1, Phase 2 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
30 |
|
Simvastatin |
Approved |
Phase 2 |
|
79902-63-9 |
54454 |
Synonyms:
(+)-Simvastatin
(1S,3R,7S,8S,8AR)-8-{2-[(2R,4R)-4-HYDROXY-6-OXOOXAN-2-YL]ETHYL}-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL 2,2-DIMETHYLBUTANOATE
2,2-Dimethylbutyrate, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
C10AA01
Cholestat
Coledis
Colemin
Corolin
Denan
Eucor
FLOLIPID
Kolestevan
Labistatin
LACERSA
Lipex
Lipinorm
Liponorm
Lipovas
Lodales
Medipo
MK-0733
MK-733
MK-733|Zocor®
Modutrol
Nivelipol
Nor-vastina
Pantok
Pepstatin
RANZOLONT
|
Rechol
Rendapid
Simcor
Simovil
SIMVADOR
SIMVASTATIN
Simvastatin [Usan:Ban:Inn]
SIMVASTATIN HYDROXY ACID
Simvastatin lactone
Simvastatina
Simvastatina [Spanish]
Simvastatine
Simvastatine [French]
Simvastatinum
Simvastatinum [Latin]
Simvotin
Sinvacor
Sinvascor
SIV691
Sivastin
Statin
Synvinolin
Valemia
Vasotenal
Velostatin
Vytorin
Zocor
ZOCOR HEART-PRO
Zocord
|
|
31 |
|
Cholecalciferol |
Approved, Nutraceutical, Vet_approved |
Phase 2 |
|
67-97-0, 1406-16-2 |
5280795 10883523 |
Synonyms:
(+)-Vitamin D3
(1S,3Z)-3-[(2E)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(1R)-1,5-DIMETHYLHEXYL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-1-CYCLOHEXANOL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(1R)-1,5-DIMETHYLHEXYL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENECYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-{2-[(1R,4E,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXAN-1-OL
(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3BETA,Z,7E)-9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-OL
(3Î’,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-SECOCHOLESTA-5,7,10-TRIEN-3-OL
(5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
3-BETA,Z,7E-9,10-SECOCHOLESTR-5,7,10(19)-TRIEN-3-OL
7-DEHYDROCHOLESTEROL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3BETA-OL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-BETA-OL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-OL
9,10-SECOCHOLESTA-5,7,10-TRIEN-3-OL
ACCRETE D3
ACIFEROL D3
ACTIVATED
Activated 7-dehydrocholesterol
ADCAL-D3
ARACHITOL
AVITICOL
BIOLIFE VITAMIN D3
BIO-VITAMIN D3
CACIT D3
CALCEOS
CALCICHEW D3
CALCICHEW D3 FTE
CALCICHEW D3 ONCE DAILY
CALCI-D
Calciferol
Calciol
CALDRINK D3
CALFOVIT D3
CC
Cholecalciferol
CHOLECALCIFEROL D3
Cholecalciferols
Cholecalciferolum
COLECAL D3
Colecalciferol
Colecalciferolum
COLEKAL-D3
COLEVIT D3
CUBICOLE D3
D3 LEMON MELTS
D3-50
D3-VIGANTOL
DEKRISTOL
DELSTEROL
Delta-D
DEPARAL
DESUNIN
DEVARON
Dihydrocholesterol
DLUX 400
D-MAX
D-TRACETTEN
|
D-VIT3
EBIVIT
E-D3
EVACAL D3
FERACOL
FULTIUM DAILY D3
FULTIUM-D3
GRANUVIT D3
HUX D3
INVITA D3
ISO D3
KORA LIQUID
MICRO-DEE
NATECAL D3
NATURE'S REMEDY VITAMIN D3
NEO-D
NPHD3
NSC-375571
Oleovitamin D3
OSTEOCAPS D3
PLENACHOL
PRO D3
PRO D3 FOLIC
PRO D3 FORTE
PROVITINA
QUINTOX
RICKETON
ROYALVIT D3
STEXEROL-D3
STIVIT-D3
SUNVIT-D3 1,000
SUNVIT-D3 10,000
SUNVIT-D3 2,000
SUNVIT-D3 20,000
SUNVIT-D3 3,000
SUNVIT-D3 400
SUNVIT-D3 5,000
SUNVIT-D3 50,000
SUNVIT-D3 800
SYNERVIT-D3
THEICAL D-3
THORENS
TRIVITAN
VIDDE-3-HYDROSOL
VI-DE3
VIDEKHOL
VIGANTOL
VIGANTOLETTEN
VIGANTOLETTEN 500
VIGORSAN
VIT D3 STREULI
VITA-D3
VITAMIN D
Vitamin D 3
VITAMIN D ASSAY SYSTEM SUITABILITY
Vitamin D NOS
Vitamin D, unspecified form
Vitamin D3
Vitamin D-3
VITINC DAN-DEE-3
ZYMAD
δ-D
|
|
32 |
|
Antibiotics, Antitubercular |
|
Phase 2 |
|
|
|
33 |
|
Anti-Bacterial Agents |
|
Phase 2 |
|
|
|
34 |
|
Anti-Infective Agents |
|
Phase 2 |
|
|
|
35 |
|
abobotulinumtoxinA |
|
Phase 1, Phase 2 |
|
|
|
Synonyms:
ABOBOTULINUMTOXINA
BONT/A
BONTOXILYSIN A
BOTOX
BOTULINUM TOXIN TYPE A
|
BOTULINUM TOXINS, TYPE A
BOTULOTOXIN A
BTX-A
ONABOTULINUMTOXINA
|
|
36 |
|
Botulinum Toxins, Type A |
|
Phase 1, Phase 2 |
|
|
|
37 |
|
Botulinum Toxins |
|
Phase 1, Phase 2 |
|
|
|
38 |
|
Cholinergic Agents |
|
Phase 1, Phase 2 |
|
|
|
39 |
|
beta-Lactamase Inhibitors |
|
Phase 2 |
|
|
|
40 |
|
Antimetabolites |
|
Phase 2 |
|
|
|
41 |
|
Hypolipidemic Agents |
|
Phase 2 |
|
|
|
42 |
|
Anticholesteremic Agents |
|
Phase 2 |
|
|
|
43 |
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors |
|
Phase 2 |
|
|
|
44 |
|
Lipid Regulating Agents |
|
Phase 2 |
|
|
|
45 |
|
Vitamins |
|
Phase 2 |
|
|
|
46 |
|
Calciferol |
|
Phase 2 |
|
|
|
47 |
|
Antioxidants |
|
Phase 2 |
|
|
|
48 |
|
Protective Agents |
|
Phase 2 |
|
|
|
49 |
|
Gastrointestinal Agents |
|
Phase 1, Phase 2 |
|
|
|
50 |
|
7-dehydrocholesterol |
|
Phase 1, Phase 2 |
|
434-16-2 |
439423 |
Synonyms:
(-)-7-Dehydrocholesterol
(3b)-Cholesta-5,7-dien-3-ol
(3beta)-Cholesta-5,7-dien-3-ol
(3Î’)-cholesta-5,7-dien-3-ol
10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
17-(1,5-Dimethylhexyl)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
5,7-Cholestadien-3beta-ol
5,7-Cholestadien-3-beta-ol
5,7-Cholestadien-3b-ol
5,7-Cholestadien-3-b-ol
5,7-Cholestadien-3β-ol
5,7-Cholestadien-3-β-ol
5,7-Cholestandien-3beta-ol
5,7-Cholestandien-3-ol
7,8-Dehydro-cholesterol
7,8-Didehydrocholesterol
7-Dehydrocholesterin
7-Dehydro-cholesterol
7-Dehydrocholesterol, (3alpha)-isomer
7-Dehydrocholesterol, (3beta,10alpha)-isomer
|
7-Dehydrocholesterol, (3beta,9beta)-isomer
7-Dehydrocholesterol, (3beta,9beta,10alpha)-isomer
7DHC
7-DHC
Cholesta-5,7-dien-3 beta -ol
Cholesta-5,7-dien-3 beta-ol
Cholesta-5,7-dien-3beta-ol
Cholesta-5,7-dien-3-beta-ol
Cholesta-5,7-dien-3b-ol
Cholesta-5,7-dien-3-ol
Cholesta-5,7-dien-3β-ol
Dehydrocholesterin
Dehydrocholesterol
Delta5,7-Cholestadien-3beta-ol
Delta5,7-Cholesterol
Delta7-Cholesterol
Provitamin D(3)
Provitamin D3
Provitamin-D3
|
|
Interventional clinical trials:
(show top 50)
(show all 106)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Double Blind Randomized Study Into the Efficacy of Codeine Phosphate Analgesia After Cleft Palate Repair in Infants |
Completed |
NCT00386269 |
Phase 4 |
Codeine Phosphate Analgesia |
2 |
Acid Tranexamic Effectiveness in Reducing the Intraoperative Bleeding in Palatoplasty : Randomized Study |
Completed |
NCT02422056 |
Phase 4 |
Tranexamic Acid;Saline |
3 |
The Impact of Adding Ultrasound Guided Bilateral Suprazygomatic Maxillary Nerve Block to General Anesthesia on Systemic Inflammatory Response in Cleft Palate Surgeries ; A Randomized Control Trial |
Recruiting |
NCT05495750 |
Phase 4 |
Bupivacaine 0.25% Injectable Solution |
4 |
The Use of Fibrin Sealant to Reduce Post Operative Pain in Cleft Palate Surgery |
Withdrawn |
NCT02953145 |
Phase 4 |
Tisseel |
5 |
A Randomized, Double-Blinded, Placebo Controlled Trial Using Single Dose Dexmedetomidine In The Treatment Of Pain In Patients Undergoing Cleft Palate Repair |
Withdrawn |
NCT02915042 |
Phase 4 |
Dexmedetomidine;Placebo |
6 |
Comparative Study Between Levobupivacaine and Bupivacaine for Nerve Block During Pediatric Primary Cleft Palate Surgery |
Completed |
NCT02923869 |
Phase 2, Phase 3 |
Levobupivacaine;Bupivacaine |
7 |
Oral Cleft Prevention Program |
Completed |
NCT00397917 |
Phase 3 |
Folic acid: 4 mg versus 0.4 mg per day |
8 |
Oral Cleft Prevention Trial in Brazil |
Completed |
NCT00098319 |
Phase 3 |
Folic acid (0.4mg vs. 4.0mg) |
9 |
Optic Nerve Sheath Diameter (ONSD): A New Modality to Assess Postoperative Agitation After a Single Bolus of Dexmedetomidine Versus Nalbuphine in Children With Cleft Palate Repair |
Recruiting |
NCT04928391 |
Phase 3 |
Dexmedetomidine;Nalbuphine |
10 |
Preemptive Nebulized Bupivacaine for Pain Control After Cleft Palate Repair in Children: A Randomized Double Blind Controlled Trial |
Recruiting |
NCT04928352 |
Phase 3 |
Bupivacaine Hydrochloride |
11 |
The Effects of Dietary Cholesterol in the Smith-Lemli-Opitz Syndrome |
Unknown status |
NCT00004347 |
Phase 2 |
|
12 |
Distraction Versus Orthognathic Surgery - Which One is Better for Cleft Palate Patients |
Completed |
NCT00930124 |
Phase 2 |
|
13 |
Evaluation of Postoperative Analgesic Effects of Bilateral Suprazygomatic Maxillary Nerve Block Using Bupivacaine and Dexmedetomidine in Children Undergoing Cleft Palate Repair Under General Anesthesia:Randomized Controlled Trial |
Completed |
NCT03412474 |
Phase 2 |
Bupivacaine;Dexmedetomidine;paracetamol |
14 |
Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair |
Completed |
NCT02247193 |
Phase 1, Phase 2 |
Botulinum Toxin Type A;Normal Saline Injection |
15 |
Efficacy of Preoperative Prophylactic Antibiotics in Preventing Complications in the Primary Repair of Cleft Palates |
Completed |
NCT00760006 |
Phase 2 |
Unasyn |
16 |
Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome |
Completed |
NCT00272844 |
Phase 1, Phase 2 |
crystalline cholesterol oil-based suspension |
17 |
Velopharyngeal Function for Speech After Palatal Surgery |
Completed |
NCT00004639 |
Phase 2 |
|
18 |
Short-Term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome |
Completed |
NCT00114634 |
Phase 2 |
|
19 |
Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome |
Completed |
NCT00064792 |
Phase 2 |
Simvastatin Susp.;OraPlus |
20 |
Cell Therapy for Craniofacial Bone Defects |
Completed |
NCT01616953 |
Phase 1, Phase 2 |
|
21 |
Dose Use of Rigid Fixation After Removing the Distraction Device Reduce the Anterior-posterior Relapse or Not? |
Completed |
NCT02350803 |
Phase 2 |
|
22 |
Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS) |
Recruiting |
NCT01773278 |
Phase 2 |
Antioxidants;Cholesterol |
23 |
Smith-Lemli-Opitz Syndrome: A Pilot Study of Cholic Acid Supplementation |
Active, not recruiting |
NCT03720990 |
Phase 1, Phase 2 |
Cholic Acid |
24 |
A Prospective, Double-Blinded, Randomized Comparison of Intravenous Acetaminophen Versus Placebo in Children Undergoing Palatoplasty |
Withdrawn |
NCT01760330 |
Phase 2 |
IV acetaminophen;Placebo |
25 |
Ketodex Versus Opioid Based Anaesthesia in Cleft Palate Repair |
Recruiting |
NCT05402189 |
Phase 1 |
Ketodex, Fentanyl |
26 |
Evaluation of Postoperative Analgesic Effects of Infraorbital Nerve Block by Levobupivacaine vs Ropivacaine After Cleft Palate Surgery: A Double-blinded Randomized Trial |
Unknown status |
NCT04212611 |
|
INFRA ORBITAL BLOCK |
27 |
Role of a Written Summary on Risk Recall During Consent Process for Cleft Palate Repair |
Unknown status |
NCT02595307 |
|
|
28 |
Comparative Study of Bilateral Suprazygomatic Maxillary Nerve Block and Surgical Site Infiltration for Perioperative Analgesia in Children Undergoing Cleft Palate Repair |
Unknown status |
NCT03799068 |
|
|
29 |
The Effect of Adjunctive Use of Low Level Laser (LLL) After Surgical Correction of Isolated Cleft Palate Versus Surgical Correction Without LLL in Healing Process |
Unknown status |
NCT03688737 |
|
|
30 |
Evaluation of the Incidence of Palatal Fistula in Furlow Double-opposing Z-plasty vs. Two-flap Palatoplasty for Cleft Palate Repair |
Unknown status |
NCT03055637 |
|
|
31 |
Evaluation of Bone-borne Palatal Expander in Conjunction With Maxillary Osteotomy in the Treatment of Cleft Palate Patients |
Unknown status |
NCT03837652 |
|
|
32 |
Analgesic Contribution of the Suprazygomatic Maxillary Nerve Block for Cleft Palate Surgery in Children |
Unknown status |
NCT04023825 |
|
suprazygomatic maxillary nerve block |
33 |
Comparing Two Peripheral Nerve Block Techniques for Perioperative Analgesia During Cleft Palate Surgery in Pediatric Patients: Randomized Controlled Trial |
Unknown status |
NCT04467463 |
|
|
34 |
Validation of a Production Method of Stem Cell Isolated From the Nasal Cavity for an Innovative Cell Therapy of Cleft Palate |
Unknown status |
NCT02900014 |
|
|
35 |
Assessment of Intellectual Abilities for Subjects With Velopharyngeal Incompetence and Their Impact on Speech Intelligibility |
Unknown status |
NCT03898713 |
|
|
36 |
Three-dimensional Development of the Palate in Bilateral Orofacial Cleft Newborns One Year After Early Neonatal Cheiloplasty: Classic and Geometric Morphometric Evaluation |
Unknown status |
NCT03839290 |
|
|
37 |
An Analysis of the Clinical Applicability of a Three-Dimensional Imaging Platform Used to Register the Influence of Orthognathic Surgery on Facial Hard and Soft Tissue in Patients With Congenital Maxillofacial Deformities. |
Unknown status |
NCT00285714 |
|
|
38 |
Partial Adenoidectomy in Cases of Velopharyngeal Dysfunction |
Unknown status |
NCT03469973 |
|
|
39 |
Device Assisted Exercises for Improving Soft Palate and Eustachian Tube Function in Children Between Ages 6-17 With or Without Cleft Palate and With Ventilation Tubes |
Completed |
NCT03868891 |
|
|
40 |
Postoperative Complications After Cleft Palate Closure in Patients With Pierre Robin Sequence: Operative Considerations |
Completed |
NCT02658318 |
|
|
41 |
Educational Impact and Development of a Novel Cleft Palate Surgical Simulator: Improvement in Surgical Trainees' Knowledge and Confidence. |
Completed |
NCT04489680 |
|
|
42 |
The Possible Effect of Modified Restoration of Tensor Veli Palatini on Audiological and Otological Outcome in Cleft Palate Repair. |
Completed |
NCT04366674 |
|
|
43 |
Auditory Profile and Language Development in Children Operated for Cleft Palate |
Completed |
NCT04367961 |
|
|
44 |
The Effect of the Usage of Squeezable vs Standard Bottles on the Feeding Process of Infants With Cleft Lip and Palate (CLP) After Cleft Palate Surgery |
Completed |
NCT05062798 |
|
|
45 |
Otologic and Rhinologic Outcomes in Children With Cleft Palate at Age 10 Years |
Completed |
NCT03708406 |
|
|
46 |
Palatal Lengthening Using Buccinator Myomucosal Flaps With Furlow Z-plasty Technique for Primary Cleft Palate Repair (A Clinical Study) |
Completed |
NCT04346173 |
|
|
47 |
Evaluation of the Effect of Boyle-Davis Mouth Gape on Intracranial Pressure in Patients With Cleft Palate Repair by Measuring Optic Nerve Sheath Diameter |
Completed |
NCT04718558 |
|
|
48 |
Improving Outcomes in Cleft Palate Surgery Through an Audit and Feedback Intervention Directed at Surgeons |
Completed |
NCT02583100 |
|
|
49 |
Middle Ear Pressure Disregulation in Cleft Palate Patients: Form-Function Correlates |
Completed |
NCT00423072 |
|
|
50 |
Microscopic Surgical Repair of Cleft Palate With Inravelar Veloplasty |
Completed |
NCT05196555 |
|
|
Cochrane evidence based reviews: cleft palate
|